Several studies point towards an evolution of diffuse gliomas upon treatment and recurrence, where IDH1/2mut astrocytomas show most and IDHwt GBMs least changes in relapsed tumors [5, 29, 38, 57]. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).